Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    entities : Nektar therapeutics    save search

Nykode Therapeutics announces presentation of preclinical data from its second generation Vaccibody vaccine technology at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 1.21% C: -4.67%

research preclinical vaccine technology therapeutics presentation cancer pre-clinical
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
Published: 2021-12-28 (Crawled : 06:00) - globenewswire.com
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 1.18% C: -1.31%

therapeutics cel sars-cov-2 vaccine t-cell
PharmaJet Partner Nykode Therapeutics Announces Phase 1/2 Clinical Trial With Next Generation DNA-Based COVID-19 Vaccine Candidates
Published: 2021-12-14 (Crawled : 15:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 2.3% H: 3.69% C: 1.77%

covid-19 trial therapeutics covid phase 1 vaccine phase 2
Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
Published: 2021-11-23 (Crawled : 09:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.87% H: 0.18% C: -0.87%

disease infectious disease collaboration cancer vaccine license therapeutics
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
Published: 2021-10-05 (Crawled : 14:15) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 1.55% C: -5.41%

vaccine trial
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.